B9991016 – A randomized double-blind phase 3 study of Avelumab in
combination with standard of care chemo-radiotherapy (Cisplatin plus definitive
radiation therapy) versus standard of care chemo-radiotherapy in the front-line
neck treatment of patients with locally advanced squamous cell carcinoma
of the head and neck.
What type of cancer? What stage?
Head and neck cancer.
Who is eligible?
First line treatment.
How will I be treated?
All patients get definitive treatment. Patients may also get Avelumab (immunotherapy).
For physicians: more information about this specific trial at
clinicaltrials.gov.
